Cargando…
SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence()
During the outbreak of coronavirus disease 2019 (COVID-19), the identification of a SARS-CoV-2 infected case with untraceable epidemic origin has three values: (1) the region has community transmission of the virus; (2) a certain portion of population in the community is getting immunized and more i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366118/ http://dx.doi.org/10.1016/j.dcmed.2020.06.006 |
_version_ | 1783560167010336768 |
---|---|
author | Kai, Li Sirois, Pierre Ai-Guo, Dai Duan-Fang, Liao |
author_facet | Kai, Li Sirois, Pierre Ai-Guo, Dai Duan-Fang, Liao |
author_sort | Kai, Li |
collection | PubMed |
description | During the outbreak of coronavirus disease 2019 (COVID-19), the identification of a SARS-CoV-2 infected case with untraceable epidemic origin has three values: (1) the region has community transmission of the virus; (2) a certain portion of population in the community is getting immunized and more individuals have already been immunized; (3) an unpredictable future risk exists for regions where there are no infected cases with untraceable epidemic origin. Minimizing or avoiding the aggregation infection through individuals with no clinical symptoms is crucial and possible as its occurrence is mainly attributed to the local environment as opposed to the super spreader with or without clinical symptoms. As infected cases are not necessarily positive with gene test by definition, proper application of gene test is crucial in the identification of asymptomatic cases. In the early stage of an outbreak of infectious disease, gene test can be used to identify asymptomatic cases but it should not be used to exclude cases with typical clinical symptoms and signs. In the middle or late stages of an outbreak gene test should be applied in evaluation of infection rate of the population of a region, in addition to be used in spreader identification and isolation. Although asymptomatic cases are attributed to the overwhelming effect of personalized defense against pathogens, they are still a source of infection. Asymptomatic cases are considered to be Qi deficiency and with lingering toxicity in traditional Chinese medicine (TCM). Treatment in such cases, typically, involves therapy focused on replenishing the Qi, tonifying the lung, clearing the fever, and detoxification in order to return to a normal health condition. The recommended Chinese medicines include Qing Fei Pai Du Decoction, Yi Qi Qu Du Decoction, Xuan Fei Bai Du Granule, Lian Hua Qing Wen Capsule (Granule), and Jin Hua Qing Gan Granule, etc. |
format | Online Article Text |
id | pubmed-7366118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-73661182020-07-17 SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence() Kai, Li Sirois, Pierre Ai-Guo, Dai Duan-Fang, Liao Digital Chinese Medicine Article During the outbreak of coronavirus disease 2019 (COVID-19), the identification of a SARS-CoV-2 infected case with untraceable epidemic origin has three values: (1) the region has community transmission of the virus; (2) a certain portion of population in the community is getting immunized and more individuals have already been immunized; (3) an unpredictable future risk exists for regions where there are no infected cases with untraceable epidemic origin. Minimizing or avoiding the aggregation infection through individuals with no clinical symptoms is crucial and possible as its occurrence is mainly attributed to the local environment as opposed to the super spreader with or without clinical symptoms. As infected cases are not necessarily positive with gene test by definition, proper application of gene test is crucial in the identification of asymptomatic cases. In the early stage of an outbreak of infectious disease, gene test can be used to identify asymptomatic cases but it should not be used to exclude cases with typical clinical symptoms and signs. In the middle or late stages of an outbreak gene test should be applied in evaluation of infection rate of the population of a region, in addition to be used in spreader identification and isolation. Although asymptomatic cases are attributed to the overwhelming effect of personalized defense against pathogens, they are still a source of infection. Asymptomatic cases are considered to be Qi deficiency and with lingering toxicity in traditional Chinese medicine (TCM). Treatment in such cases, typically, involves therapy focused on replenishing the Qi, tonifying the lung, clearing the fever, and detoxification in order to return to a normal health condition. The recommended Chinese medicines include Qing Fei Pai Du Decoction, Yi Qi Qu Du Decoction, Xuan Fei Bai Du Granule, Lian Hua Qing Wen Capsule (Granule), and Jin Hua Qing Gan Granule, etc. 2020-06 2020-07-17 /pmc/articles/PMC7366118/ http://dx.doi.org/10.1016/j.dcmed.2020.06.006 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Kai, Li Sirois, Pierre Ai-Guo, Dai Duan-Fang, Liao SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence() |
title | SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence() |
title_full | SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence() |
title_fullStr | SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence() |
title_full_unstemmed | SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence() |
title_short | SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence() |
title_sort | sars-cov-2 infected cases with untraceable epidemic origin: its values, identification and tcm treatment in preventing recurrence() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366118/ http://dx.doi.org/10.1016/j.dcmed.2020.06.006 |
work_keys_str_mv | AT kaili sarscov2infectedcaseswithuntraceableepidemicoriginitsvaluesidentificationandtcmtreatmentinpreventingrecurrence AT siroispierre sarscov2infectedcaseswithuntraceableepidemicoriginitsvaluesidentificationandtcmtreatmentinpreventingrecurrence AT aiguodai sarscov2infectedcaseswithuntraceableepidemicoriginitsvaluesidentificationandtcmtreatmentinpreventingrecurrence AT duanfangliao sarscov2infectedcaseswithuntraceableepidemicoriginitsvaluesidentificationandtcmtreatmentinpreventingrecurrence |